JP2019513004A5 - - Google Patents

Info

Publication number

JP2019513004A5

JP2019513004A5 JP2018540464A JP2018540464A JP2019513004A5 JP 2019513004 A5 JP2019513004 A5 JP 2019513004A5 JP 2018540464 A JP2018540464 A JP 2018540464A JP 2018540464 A JP2018540464 A JP 2018540464A JP 2019513004 A5 JP2019513004 A5 JP 2019513004A5

Authority

JP

Japan

Prior art keywords

cdr

seq

residues

chain variable

variable region

Prior art date

2017-02-03

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Granted

Links

• Espacenet
• Global Dossier
• Discuss

• 239000012634 fragment Substances 0.000 claims description 62
• 101001139093 Homo sapiens Klotho Proteins 0.000 claims description 56
• 102100020686 Klotho Human genes 0.000 claims description 56
• 229920001184 polypeptide Polymers 0.000 claims description 30
• 108090000765 processed proteins & peptides Proteins 0.000 claims description 30
• 102000004196 processed proteins & peptides Human genes 0.000 claims description 30
• 108010047041 Complementarity Determining Regions Proteins 0.000 claims description 10
• 102000018233 Fibroblast Growth Factor Human genes 0.000 claims description 4
• 108050007372 Fibroblast Growth Factor Proteins 0.000 claims description 4
• 229940126864 fibroblast growth factor Drugs 0.000 claims description 4
• 108060003951 Immunoglobulin Proteins 0.000 claims description 2
• 108010021625 Immunoglobulin Fragments Proteins 0.000 claims description 2
• 102000008394 Immunoglobulin Fragments Human genes 0.000 claims description 2
• 239000003795 chemical substances by application Substances 0.000 claims description 2
• 239000000539 dimer Substances 0.000 claims description 2
• 102000018358 immunoglobulin Human genes 0.000 claims description 2
• 102000005962 receptors Human genes 0.000 claims description 2
• 108020003175 receptors Proteins 0.000 claims description 2
• 210000002966 serum Anatomy 0.000 claims description 2
• 210000002700 urine Anatomy 0.000 claims description 2
• 150000001413 amino acids Chemical group 0.000 claims 40
• BWGNESOTFCXPMA-UHFFFAOYSA-N Dihydrogen disulfide Chemical compound SS BWGNESOTFCXPMA-UHFFFAOYSA-N 0.000 claims 2
• MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 claims 1
• AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 claims 1
• OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 claims 1
• MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 claims 1
• 229940024606 amino acid Drugs 0.000 claims 1
• 229940127121 immunoconjugate Drugs 0.000 claims 1
• 229960000310 isoleucine Drugs 0.000 claims 1
• AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 claims 1
• OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 claims 1
• 239000000523 sample Substances 0.000 description 25
• 238000000034 method Methods 0.000 description 19
• 150000007523 nucleic acids Chemical class 0.000 description 11
• 208000020832 chronic kidney disease Diseases 0.000 description 9
• 238000003018 immunoassay Methods 0.000 description 9
• 125000003275 alpha amino acid group Chemical group 0.000 description 8
• 238000003556 assay Methods 0.000 description 8
• 108020004707 nucleic acids Proteins 0.000 description 8
• 102000039446 nucleic acids Human genes 0.000 description 8
• 208000009304 Acute Kidney Injury Diseases 0.000 description 7
• 208000033626 Renal failure acute Diseases 0.000 description 7
• 201000011040 acute kidney failure Diseases 0.000 description 7
• 238000001514 detection method Methods 0.000 description 6
• 238000002965 ELISA Methods 0.000 description 5
• 210000004027 cell Anatomy 0.000 description 5
• 238000004393 prognosis Methods 0.000 description 4
• 108091028043 Nucleic acid sequence Proteins 0.000 description 3
• 241000283984 Rodentia Species 0.000 description 2
• 238000001943 fluorescence-activated cell sorting Methods 0.000 description 2
• 238000001114 immunoprecipitation Methods 0.000 description 2
• 230000007774 longterm Effects 0.000 description 2
• 238000004519 manufacturing process Methods 0.000 description 2
• 238000009007 Diagnostic Kit Methods 0.000 description 1
• HVLSXIKZNLPZJJ-TXZCQADKSA-N HA peptide Chemical compound C([C@@H](C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](C)C(O)=O)NC(=O)[C@H]1N(CCC1)C(=O)[C@@H](N)CC=1C=CC(O)=CC=1)C1=CC=C(O)C=C1 HVLSXIKZNLPZJJ-TXZCQADKSA-N 0.000 description 1
• 241000124008 Mammalia Species 0.000 description 1
• 210000001124 body fluid Anatomy 0.000 description 1
• 239000010839 body fluid Substances 0.000 description 1
• 239000011248 coating agent Substances 0.000 description 1
• 238000000576 coating method Methods 0.000 description 1
• 230000002860 competitive effect Effects 0.000 description 1
• 238000012258 culturing Methods 0.000 description 1
• 239000012520 frozen sample Substances 0.000 description 1
• 238000003119 immunoblot Methods 0.000 description 1
• 238000003365 immunocytochemistry Methods 0.000 description 1
• 238000003364 immunohistochemistry Methods 0.000 description 1
• 210000003734 kidney Anatomy 0.000 description 1
• 238000011084 recovery Methods 0.000 description 1
• 238000003118 sandwich ELISA Methods 0.000 description 1
• 238000012216 screening Methods 0.000 description 1
• 239000007787 solid Substances 0.000 description 1